Gracell Biotechnologies Inc. ADR (GRCL)
NGM · ADR · CUSIP 38406L103
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for GRCL and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
38406L103
Market Cap
Small Cap
IPO
1/8/2021 · $19.00/share
ADR Ratio
1:5
Business: Gracell Biotechnologies is a global clinical-stage biopharmaceutical company dedicated to discovering and developing breakthrough cell therapies.

Company Contact

CEO
William Wei Cao
CFO
Yili Kevin Xie
Investor Relations
Gracie Tong · Gracie.tong@gracellbio.com
General Email
ir@gracellbio.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »